The company,_with registered_head_office_located in CITY,_STATE_OR_PROVINCE, is engaged in developing electronic brachytherapy systems based on miniaturized X-ray tube technology for the practice of radiation oncology. Its electronic brachytherapy involves the delivery of hardened x-ray beams which behave like an isotope that_can_be switched on or off on demand. The company 's ORGANIZATION ORGANIZATION ORGANIZATION is used in Accelerated Partial Breast Irradiation (APBI) in the treatment of early stage CAUSE_OF_DEATH_CAUSE_OF_DEATH. Its Axxent treatment platform provides a therapeutic dose of intracavitary radiation directly to the region at_risk with minimal radiation exposure to surrounding healthy tissue. The company 's products also include ORGANIZATION ORGANIZATION ORGANIZATION, a component of the Axxent Electronic Brachytherapy System that is inserted through a single incision in the breast ; and Axxent FlexiShield, a flexible lead equivalent material, which drapes over the patient treatment area to reduce radiation transmission to nearby healthy tissue and organs. Its products also include Axxent HDR X-ray Source that_allows for treatment planning and dose distribution to the target area while minimizing exposure to the nearby healthy tissue ; and Axxent Physics Accessories Kit, which_allows physicists to perform quality_assurance tests to confirm the Axxent Electronic Brachytherapy System is working properly. Formerly_known_as Xoft microTube, ORGANIZATION, it was_founded in DATE. The company aims_to_expand access_to radiation therapy.